Membrane proteins such as S1P and AC6 are highly expressed in cilia and along cell processes, which act as mediators of osteocytes mechanotransduction and they may be suitable targets for development of therapeutic drugs treating bone metabolism disorder. This evidence concerns the gene ADCY6 and metabolic bone disorder.